Pulse Biosciences, Inc.
PLSE
$13.18
-$0.07-0.53%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 7.26% | 5.90% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.88% | 12.36% | |||
| Operating Income | -0.45% | -12.36% | |||
| Income Before Tax | -1.13% | -14.13% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -1.13% | -14.13% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -1.13% | -14.13% | |||
| EBIT | -0.45% | -12.36% | |||
| EBITDA | -0.54% | -12.62% | |||
| EPS Basic | -0.98% | -13.87% | |||
| Normalized Basic EPS | -0.95% | -13.87% | |||
| EPS Diluted | -0.98% | -13.87% | |||
| Normalized Diluted EPS | -0.95% | -13.87% | |||
| Average Basic Shares Outstanding | 0.16% | 0.22% | |||
| Average Diluted Shares Outstanding | 0.16% | 0.22% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||